RRM1 and glioblastoma: Notably, mass spectrometry analyses of RRM1 immunoprecipitates from the TMZ-treated GBM cells showed that RRM1 was phosphorylated at T52 (Supplementary Fig. 4e and Supplementary Table 1), an evolutionally conserved residue (Supplementary Fig. 4f).